The analysis of LRRK2 missense variants revealed a significant association of the G2019S and N2081D variants with IBD-PD, in addition to several other variants as potential contributors to increased or decreased IBD-PD risk. This evidence concerns the gene LRRK2 and inflammatory bowel disease.